The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.
Mounjaro is a prescription drug with the active ingredient tirzepatide. It helps regulate blood sugar and may help reduce weight in people with type 2 diabetes. Here, we look at how to get ...
The U.K. government issued a new warning aimed at the misuse of GLP-1 therapies by those who don’t qualify for the meds but are instead using them for quick-fix weight loss.